Click to Share

Filter News
Show All Results
News By Country
News By Tag
Drug Development Remove

April 2020
March 2020

Public Company News

Business Press Releases

Drug Development Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Neurolixis
The United States Patent and Trademark Office (USPTO) has issued a patent on NLX-112, a drug candidate developed by Neurolixis for treatment of human movement disorders, notably levodopa-induced dyskinesia in Parkinson's disease.
By Phase Clinical Services
Phase Clinical Services, an innovation leader of clinical trial management, today announced that it has entered into a collaboration with Primary & Preventive Care of Hanover, MA, led by Dr. Rafay S. Mehdi, to advance clinical trials.
By Neurolixis, Inc.
Neurolixis Inc. has been awarded funds by the US Department of Defense to test its drug candidate, NLX-112, in a preclinical model of Machado-Joseph disease (MJD), a rare and disabling inherited movement disorder.
By Oncoheroes Biosciences Inc.
Oncoheroes Biosciences Inc. ("Oncoheroes") and Boehringer Ingelheim International GmbH ("Boehringer Ingelheim") have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered..
By Neurolixis Inc.
The Neurolixis lead compound, NLX-112, is at the heart of a brain imaging investigation of functionally-active serotonin 5-HT1A receptors in humans. NLX-112, a.k.a.
By CPC Scientific Inc.
to develop and manufacture a specific NCE for an undisclosed European biopharmaceutical partner
By SMi Group
SMi Reports: An exclusive interview with Anita Burrell, Founder & CEO at Anita Burrell Consulting and speaker at this year's 5th annual Biosimilars USA conference, is now available to download on the event website.
By Applied Informatics
Dr. Chintan Patel to discuss the implementation of AI & machine learning in clinical development.
By SMi Group
SMi Reports: An exclusive interview with Dr Michel Mikhail, an independent consultant and chairman of this year's Biosimilars & Biobetters conference, is now available to download on the event website.
By SMi Group
SMi Reports: Registration for SMi's 9th annual Biosimilars and Biobetters conference has opened and the brochure is available to download
By SMi Group
SMi Group Reports: The official agenda for the 5th annual Biosimilars USA conference, which is taking place this fall in New Jersey, USA, has been released.
By SMi Group
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.
By Keystone Symposia on Molecular & Cellular Biology
Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Drug Discovery: Current Trends in Medicinal Chemistry" on April 26, 2018 at 2:30 PM ET.

Page updated every 10 minutes

Like PRLog?
Click to Share